| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |